Serious research is picking up on the potential mental health benefits of coca plant. Despite its historical stigma related to its alkaloid cocaine, which has kept it a Schedule I in Canada and Schedule II in the U.S. the coca leaf is seeing a research renaissance.
For a better understanding of the scenario for the coca plant, Benzinga spoke with Ronan Levy, advisor-turned-president of Safe Supply Streaming Co.
Democratized Access Vs. Illicit Market Supply
Safe Supply, now trading on the Canada and Frankfurt Stock Exchanges, invests in and incubates companies working on the legal and regulated drugs supply for a “responsible end” to the War on Drugs.
Levy is a long-time expert in the cannabis and psychedelics capital markets and a lawyer in Ontario. He co-founded Canadian Cannabis Clinics and Aurora (NASDAQ: ACB)-acquired CanvasRx, among others.
With jurisdictions across the globe moving toward decriminalizing, regulating and legalizing drugs, Safe Supply invests in the infrastructure needed to support the transition: facilities for analyzing, manufacturing and distributing psychoactive substances, research and ...